▼ -46.70% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Trupanion in the last 3 months. The average price target is $62.60, with a high forecast of $95.00 and a low forecast of $40.00. The average price target represents a -46.70% upside from the last price of $117.45.
The current consensus among 7 investment analysts is to hold stock in Trupanion. This rating has held steady since September 2019, when it changed from a Buy consensus rating.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.